301.694.2999

DONATE

Blog

 

Countdown to Tech Showcase 2026 ▶︎ Company Spotlight: CFrame

With the 2026 Tech Showcase fast approaching we are spotlighting FITCI companies leading up to it. Follow along to learn more about the companies featured in this years Tech Showcase, and the groundbreaking technology, research, and science happening in right here in Frederick. Discredited human experience, disconnection, and unrealized potential are just some of the … Read more

August 2025 FITCI Updates

July 2025 FITCI Updates

June 2025 FITCI Updates

Venable: Power Partner Fuels Innovation for FITCI’s Science & Technology Entrepreneurs

20 FITCI Companies That Will Change the World

BioEvanesce: Pioneering Solutions for Post-Surgical Scar Tissue Adhesions

In June 2024, BioEvanesce established its laboratory at FITCI, Frederick’s leading incubator for life sciences and technology startups. The company is on a mission to tackle a pervasive and often overlooked post-surgical complication that affects millions of patients each year: Scar Tissue Adhesions. “Adhesions are the bane of surgeons’ existence,” says BioEvanesce founder, Erin Evke, a PhD … Read more

Theradaptive Grows Again; Celebrates Ribbon-Cutting

September 19, 2024 – Founded in 2016, FITCI Grad Theradaptive is growing again. The company is commercializing a pipeline of therapeutics in the orthopedic space, targeting multiple clinical applications, including spinal fusion, long bone repair, dental repair, osteochondral reconstruction, and peripheral nerve repair. It launched from FITCI’s Metropolitan Court facility with 6 employees during the … Read more

Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005

— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders  — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. 14, 2024 – Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan … Read more

Partner Spotlight: InfoPathways – Allies and Advocates for Human IT

Exploring InfoPathways and their remarkable support of FITCI and the entrepreneurs we serve! This partnership, sparked by a referral, has blossomed into a powerful alliance, showcasing InfoPathways’ unwavering commitment to nurturing emerging businesses and fostering a vibrant, economically healthy community. Theresa Bethune, founder of InfoPathways, connected with FITCI through one of our startup clients who … Read more

1239 Next